๐Ÿ‡บ๐Ÿ‡ธ BRC Therapeutics Joins FDA and EMA Regulators at Workshop Advancing the Future of Botanical Drug Development

๐Ÿ‡บ๐Ÿ‡ธ

Company Applauds FDA and EMA Leadership as Regulators Prioritize a Clear Pathway for Botanical Medicines to Reach Patients MONTEREY, Calif., Sept. 28, 2026 /PRNewswire/ — BRC Therapeutics (BRC), a clinical-stage pharmaceutical company developing multimodal cannabinoid therapeutics for…

Source: prnewswire

Country: United States